A Great Info Post from visceraljunket1 on YMB on things INO does:
Inovio has targeted many of the world's most deadly diseases.
1. Cervical dysplasia HPV Type 16/18 -VGX-3100
2. Cervical cancer HPV Type 16/18 -INO-3112
3. Head & neck cancer
HPV Type 16/18- INO-3112
4. Aerodigestive cancer
HPV Type 6 -INO-3106
5. Prostate cancer -INO-5150
6. Breast, lung, & pancreatic cancer -INO-1400
7. Hepatitis BClades A & C -INO-1800
8. Hepatitis C Genotype 1a & 1b -INO-8000
. 9HIV Clade B -PENNVAX®-B
10. HIV Clades A, C, D -PENNVAX®-G
11. HIV Clades A, C (B) -PENNVAX®-GP
12. Influenza - Universal -Various
13.Malaria -Various
14.Ebola -Various
Also Inovio has developed SynCon® vaccines against Clostridium difficile, tuberculosis, foot-and-mouth disease (for animals), dengue fever, Chikungunya virus, and other tropical infectious diseases, some which pose potential risk for bioterrorism use.
Developing MERS Virus Vaccine, Dr. Joseph Kim and Dr. David Weiner discuss the MERS virus and Inovio’s effort to create a potential DNA vaccine to combat this infectious disease.
PAD: "Inovio highlighted another new application of DNA technology in a paper discussing the ability to stimulate blood vessel growth, limb function recovery and survival from limb necrosis and amputation, which may be beneficial for the treatment of critical limb ischemia and other forms of peripheral arterial disease. This result was achieved with
Inovio's DNA therapy encoded for hypoxia-inducible factor-1 alpha or HIF-1 alpha. Results from this mice study were published in the Journal of Vascular Surgery. Patients with peripheral arterial disease have very limited treatment options, and this is a multi-billion dollar market opportunity"
For more detailed information, visit Inovio's website as well as several very informative facebook pages. as well!